View the ABEVMY 400 registration information details.
Back to drug list
ItemsDrug Registration information
ID403
No403
Brand NameABEVMY 400
IngredientsBEVACIZUMAB (R-DNA ) 400 MG/16 ML
Dosage FormSOLUTION FOR INFUSION
Primary PackagingVIAL
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 1 VIAL X 16 ML
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF ADULT PATIENTS WITH METASTATIC CARCINOMA OF TH E COLON OR RECTUM (IN COMBINATION WITH FLUOROPYRIMIDINE BASED CHEMOTHERAPY)
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionCLEAR TO SLIGHTLY OPALESCENT, COLORLESS TO PALE BROWN LIQUID
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerBIOCON LIMITED
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No08 I 5269/22
FDD Registration Date26/08/2022
Expiry Date25/08/2025
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA